Structuring of a Lung Cancer Screening Program Including Clinical, Radiological and Biological Phenotyping Useful for the Development of Individualized Risk Prediction Tools: PREVALUNG ETOILE

NCT05649046 · clinicaltrials.gov ↗

NA

Phase

UNKNOWN

Status

160

Enrollment

OTHER

Sponsor class

Conditions

Smoking-related Pathology
Atheroma
Chronic Bronchitis
Non-progressive Cancer > 5 Years
Lung Cancer

Interventions

DEVICE: thoracic scan Low dose
BIOLOGICAL: BLOOD SAMPLE
BIOLOGICAL: FECES SAMPLE

Sponsor

Assistance Publique Hopitaux De Marseille